AstraZeneca

COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they're a double-edged sword for J&J and AZ
Fierce Pharma
Thu, 01/20/22 - 11:23 pm
Pfizer
Moderna Therapeutics
JNJ
AstraZeneca
COVID-19
vaccines
reputation
AstraZeneca bets $75M on Scorpion’s precision approach to tough cancer targets
MedCity News
Fri, 01/14/22 - 11:22 am
AstraZeneca
Scorpion Therapeutics
cancer
small molecule drugs
After nabbing two AI-generated molecules, AstraZeneca returns to BenevolentAI with new collaboration
Endpoints
Fri, 01/14/22 - 11:12 am
AstraZeneca
BenevolentAI
machine learning
artificial intelligence
Biotech investors pray for a takeover miracle
EP Vantage
Fri, 01/14/22 - 11:09 am
M&A
biotech
Amylyx Pharmaceuticals
Arena Pharmaceuticals
AstraZeneca
Aurinia Pharmaceuticals
Biogen
Biohaven
Bristol Myers Squibb
Eli Lilly
GSK
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
FDA
adagrasib
donanemab
faricimab
lecanemab
tezepelumab
tirzepatide
vutrisiran
Eli Lilly
Mirati Therapeutics
Roche
Chugai
Eisai
Biogen
AstraZeneca
Amgen
Alnylam
JPM22, Day 3: BeiGene, Ionis promise 'tidal wave' of new drugs; Roche launches smart, point-of-care glucose monitor
Fierce Biotech
Wed, 01/12/22 - 11:12 am
JPMHC 2022
BeiGene
Ionis Pharmaceuticals
Roche
devices
AstraZeneca
Biogen
AstraZeneca and Neurimmune to develop investigational human monoclonal antibody NI006
Biopharma Reporter
Mon, 01/10/22 - 11:43 am
Alexion
AstraZeneca
Neurimmune
NI006
ATTR-CM
AstraZeneca goes bigger in amyloidosis with Neurimmune deal
Pharmaforum
Fri, 01/7/22 - 10:33 am
AstraZeneca
ATTR
Neurimmune
NI006
AstraZeneca, Amgen tap Brand Institute in new naming twist for their freshly approved Tezspire
Fierce Pharma
Thu, 01/6/22 - 11:52 am
Amgen
AstraZeneca
Broad Institute
asthma
Tezspire
drug names
Ovid signs license deal with AstraZeneca to expand epilepsy drug pipeline
Pharmaceutical Business Review
Tue, 01/4/22 - 10:16 am
Ovid Therapeutics
AstraZeneca
small molecule drugs
epilepsy
AstraZeneca, Ionis close deal on antisense therapy development
Pharmaceutical Business Review
Thu, 12/30/21 - 11:07 am
AstraZeneca
Ionis Pharmaceuticals
antisense
eplontersen
AstraZeneca and Amgen’s asthma biologic approved in the US
Biopharma Reporter
Mon, 12/20/21 - 11:08 am
AstraZeneca
Amgen
Tezspire
FDA
severe asthma
Go or no go? Roche’s fresh start for a new year
EP Vantage
Mon, 12/20/21 - 10:59 am
FDA
Roche
Novartis
Pfizer
AstraZeneca
Cibinqo
Lynparza
Tezspire
Vyvgart
faricimab
This New Study Could Give Moderna a Big Advantage in 2022
Motley Fool
Sat, 12/18/21 - 10:46 pm
Moderna Therapeutics
Pfizer
AstraZeneca
COVID-19
vaccines
boosters
Viatris gets shot to shed infringement claims in long-running patent kerfuffle on AstraZeneca's Symbicort
Fierce Pharma
Tue, 12/14/21 - 11:33 pm
Viatris
generics
Symbicort
AstraZeneca
patents
COPD
asthma
2021: the year mRNA therapeutics came of age
Pharmaforum
Mon, 12/13/21 - 10:55 am
MRNA
vaccines
COVID-19
Sanofi
AstraZeneca
Moderna Therapeutics
Pfizer
BioNTech
AstraZeneca's COVID therapy becomes first antibody approved for immunocompromised people preexposure
Fierce Pharma
Wed, 12/8/21 - 11:35 pm
AstraZeneca
COVID-19
antibodies
FDA
Emergency Use Authorization
AZ, Daiichi take aim at Gilead in triple-negative breast cancer
Pharmaforum
Wed, 12/8/21 - 10:37 am
AstraZeneca
Daiichi Sankyo
Gilead Sciences
Trodelvy
triple negative breast cancer
Dato-DXd
AstraZeneca wagers $200M on Ionis' next chance at a rare disease drug
BioPharma Dive
Tue, 12/7/21 - 10:48 am
AstraZeneca
Ionis Pharmaceuticals
transthyretin amyloidosis
eplontersen
AstraZeneca weighs spinning out COVID-19 products into separate company: Bloomberg
Fierce Pharma
Mon, 12/6/21 - 10:56 am
AstraZeneca
spinoffs
COVID-19
vaccines

Pages